Bank Of New York Mellon Corp Verastem, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.33 - $10.44 $46,901 - $1.48 Million	142,127 New	142,127 $56,000
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.83 $510,432 - $915,775	-500,424 Reduced 77.82%	142,651 $165,000
Q4 2021 Feb 11, 2022	BUY	$2.05 - $3.2 $27,662 - $43,180	13,494 Added 2.14%	643,075 $1.32 Million
Q3 2021 Nov 12, 2021	BUY	$2.54 - $4.07 $120,634 - $193,300	47,494 Added 8.16%	629,581 $1.94 Million
Q2 2021 Aug 11, 2021	SELL	$2.57 - $4.85 $132,935 - $250,871	-51,726 Reduced 8.16%	582,087 $2.37 Million
Q1 2021 May 13, 2021	SELL	$1.9 - $2.82 $32,512 - $48,255	-17,112 Reduced 2.63%	633,813 $1.57 Million
Q4 2020 Feb 09, 2021	SELL	$1.15 - $2.4 $23,462 - $48,964	-20,402 Reduced 3.04%	650,925 $1.39 Million
Q3 2020 Nov 12, 2020	BUY	$1.11 - $1.68 $11,326 - $17,142	10,204 Added 1.54%	671,327 $812,000
Q2 2020 Aug 12, 2020	BUY	$1.69 - $4.2 $828,791 - $2.06 Million	490,409 Added 287.27%	661,123 $1.14 Million
Q1 2020 May 06, 2020	BUY	$1.26 - $3.38 $38,350 - $102,877	30,437 Added 21.7%	170,714 $450,000
Q3 2019 Nov 07, 2019	BUY	$1.21 - $1.59 $30,270 - $39,777	25,017 Added 21.7%	140,277 $169,000
Q2 2019 Aug 12, 2019	SELL	$1.25 - $3.14 $125,131 - $314,329	-100,105 Reduced 46.48%	115,260 $174,000
Q1 2019 May 14, 2019	SELL	$2.79 - $4.09 $1,475 - $2,163	-529 Reduced 0.25%	215,365 $638,000
Q4 2018 Feb 11, 2019	SELL	$3.23 - $7.01 $46,918 - $101,827	-14,526 Reduced 6.3%	215,894 $725,000
Q3 2018 Nov 09, 2018	SELL	$6.86 - $9.97 $838,978 - $1.22 Million	-122,300 Reduced 34.67%	230,420 $0
Q2 2018 Aug 06, 2018	BUY	$2.88 - $8.67 $905,474 - $2.73 Million	314,401 Added 820.48%	352,720 $2.43 Million
Q1 2018 May 15, 2018	BUY	$2.92 - $3.81 $15,569 - $20,314	5,332 Added 16.16%	38,319 $114,000
Q4 2017 Feb 09, 2018	BUY	$2.99 - $4.85 $98,631 - $159,986	32,987	32,987 $101,000

Others Institutions Holding VSTM

# of Institutions

Shares Held

297K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

225K
Shares

$1.38 Million
0.14% of portfolio
Beaumont Financial Partners, LLC

48K
Shares

$293,760
0.0% of portfolio
Eaton Vance Management Boston, MA

20K
Shares

$122,400
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.99K
Shares

$18,268
0.0% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.07K
Shares

$6,572
0.0% of portfolio

View Full List

About Verastem, Inc.

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.29B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

More about VSTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account